Who benefits from R0 resection? A single-center analysis of patients with stage Ⅳ gallbladder cancer

Objectives: Most patients with gallbladder cancer (GBC) present with advanced-stage disease and have a poor prognosis. Radical resection remains the only therapeutic option to improve survival in patients with GBC. This study aimed to analyze the prognostic factors in patients with stage Ⅳ GBC and t...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Chen Chen, Lin Wang, Rui Zhang, Qi Li, Ya-Ling Zhao, Guan-Jun Zhang, Wen-Zhi Li, Zhi-Min Geng
Formato: article
Lenguaje:EN
Publicado: KeAi Communications Co., Ltd. 2019
Materias:
Acceso en línea:https://doaj.org/article/b394115aad694fe6b33eae4a3006c457
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:b394115aad694fe6b33eae4a3006c457
record_format dspace
spelling oai:doaj.org-article:b394115aad694fe6b33eae4a3006c4572021-12-02T16:02:32ZWho benefits from R0 resection? A single-center analysis of patients with stage Ⅳ gallbladder cancer2095-882X10.1016/j.cdtm.2019.08.004https://doaj.org/article/b394115aad694fe6b33eae4a3006c4572019-09-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2095882X19300696https://doaj.org/toc/2095-882XObjectives: Most patients with gallbladder cancer (GBC) present with advanced-stage disease and have a poor prognosis. Radical resection remains the only therapeutic option to improve survival in patients with GBC. This study aimed to analyze the prognostic factors in patients with stage Ⅳ GBC and to identify a subgroup of patients who might benefit from R0 resection. Methods: A total of 285 patients with stage Ⅳ GBC were retrospectively analyzed at our institution from January 2008 to December 2012. Factors potentially influencing the prognosis of GBC after surgery were analyzed by univariate and multivariate analyses. Results: The 1-, 3-, and 5-year overall survival rates were 6.6% (15/229), 0.9% (2/229), and 0 (0/229), respectively. Ascites (relative risk [RR] = 1.631, 95% confidence interval [CI]: 1.221–2.180, P = 0.001), pathological grade (RR = 1.337, 95% CI: 1.050–1.702, P = 0.018), T stage (RR = 1.421, 95% CI: 1.099–1.837, P = 0.000), M stage (RR = 1.896, 95% CI: 1.409–2.552, P = 0.000), and surgery (RR = 1.542, 95% CI: 1.022–2.327, P = 0.039) were identified as independent risk factors influencing prognosis. The median survival time (MST) was significantly higher in patients undergoing R0 resection than in those undergoing R1/R2 resection (6.0 vs. 2.7 months; P < 0.001). In subgroup analyses, stage ⅣA patients benefited from R0 resection (MST for R0 vs. R1/R2, 11.0 vs. 4.0 months; P = 0.003), while R0 resection had a significant survival benefit than R1/R2 resection in patient with stage ⅣB GBC without distant metastasis (MST for R0 vs. R1/R2, 6.0 vs. 3.0 months; P = 0.007). Conclusion: Ascites, pathological grade, T stage, M stage, and surgery were independent risk factors influencing prognosis in patients with stage IV GBC. N2 lymph node metastasis did not preclude curative resection, and radical resection should be considered in patients with stage Ⅳ GBC without distant metastasis once R0 margin was achieved. Keywords: Gallbladder cancer, Surgery, Prognosis, Tumor-node-metastasis (TNM) stageChen ChenLin WangRui ZhangQi LiYa-Ling ZhaoGuan-Jun ZhangWen-Zhi LiZhi-Min GengKeAi Communications Co., Ltd.articleMedicine (General)R5-920ENChronic Diseases and Translational Medicine, Vol 5, Iss 3, Pp 188-196 (2019)
institution DOAJ
collection DOAJ
language EN
topic Medicine (General)
R5-920
spellingShingle Medicine (General)
R5-920
Chen Chen
Lin Wang
Rui Zhang
Qi Li
Ya-Ling Zhao
Guan-Jun Zhang
Wen-Zhi Li
Zhi-Min Geng
Who benefits from R0 resection? A single-center analysis of patients with stage Ⅳ gallbladder cancer
description Objectives: Most patients with gallbladder cancer (GBC) present with advanced-stage disease and have a poor prognosis. Radical resection remains the only therapeutic option to improve survival in patients with GBC. This study aimed to analyze the prognostic factors in patients with stage Ⅳ GBC and to identify a subgroup of patients who might benefit from R0 resection. Methods: A total of 285 patients with stage Ⅳ GBC were retrospectively analyzed at our institution from January 2008 to December 2012. Factors potentially influencing the prognosis of GBC after surgery were analyzed by univariate and multivariate analyses. Results: The 1-, 3-, and 5-year overall survival rates were 6.6% (15/229), 0.9% (2/229), and 0 (0/229), respectively. Ascites (relative risk [RR] = 1.631, 95% confidence interval [CI]: 1.221–2.180, P = 0.001), pathological grade (RR = 1.337, 95% CI: 1.050–1.702, P = 0.018), T stage (RR = 1.421, 95% CI: 1.099–1.837, P = 0.000), M stage (RR = 1.896, 95% CI: 1.409–2.552, P = 0.000), and surgery (RR = 1.542, 95% CI: 1.022–2.327, P = 0.039) were identified as independent risk factors influencing prognosis. The median survival time (MST) was significantly higher in patients undergoing R0 resection than in those undergoing R1/R2 resection (6.0 vs. 2.7 months; P < 0.001). In subgroup analyses, stage ⅣA patients benefited from R0 resection (MST for R0 vs. R1/R2, 11.0 vs. 4.0 months; P = 0.003), while R0 resection had a significant survival benefit than R1/R2 resection in patient with stage ⅣB GBC without distant metastasis (MST for R0 vs. R1/R2, 6.0 vs. 3.0 months; P = 0.007). Conclusion: Ascites, pathological grade, T stage, M stage, and surgery were independent risk factors influencing prognosis in patients with stage IV GBC. N2 lymph node metastasis did not preclude curative resection, and radical resection should be considered in patients with stage Ⅳ GBC without distant metastasis once R0 margin was achieved. Keywords: Gallbladder cancer, Surgery, Prognosis, Tumor-node-metastasis (TNM) stage
format article
author Chen Chen
Lin Wang
Rui Zhang
Qi Li
Ya-Ling Zhao
Guan-Jun Zhang
Wen-Zhi Li
Zhi-Min Geng
author_facet Chen Chen
Lin Wang
Rui Zhang
Qi Li
Ya-Ling Zhao
Guan-Jun Zhang
Wen-Zhi Li
Zhi-Min Geng
author_sort Chen Chen
title Who benefits from R0 resection? A single-center analysis of patients with stage Ⅳ gallbladder cancer
title_short Who benefits from R0 resection? A single-center analysis of patients with stage Ⅳ gallbladder cancer
title_full Who benefits from R0 resection? A single-center analysis of patients with stage Ⅳ gallbladder cancer
title_fullStr Who benefits from R0 resection? A single-center analysis of patients with stage Ⅳ gallbladder cancer
title_full_unstemmed Who benefits from R0 resection? A single-center analysis of patients with stage Ⅳ gallbladder cancer
title_sort who benefits from r0 resection? a single-center analysis of patients with stage ⅳ gallbladder cancer
publisher KeAi Communications Co., Ltd.
publishDate 2019
url https://doaj.org/article/b394115aad694fe6b33eae4a3006c457
work_keys_str_mv AT chenchen whobenefitsfromr0resectionasinglecenteranalysisofpatientswithstageivgallbladdercancer
AT linwang whobenefitsfromr0resectionasinglecenteranalysisofpatientswithstageivgallbladdercancer
AT ruizhang whobenefitsfromr0resectionasinglecenteranalysisofpatientswithstageivgallbladdercancer
AT qili whobenefitsfromr0resectionasinglecenteranalysisofpatientswithstageivgallbladdercancer
AT yalingzhao whobenefitsfromr0resectionasinglecenteranalysisofpatientswithstageivgallbladdercancer
AT guanjunzhang whobenefitsfromr0resectionasinglecenteranalysisofpatientswithstageivgallbladdercancer
AT wenzhili whobenefitsfromr0resectionasinglecenteranalysisofpatientswithstageivgallbladdercancer
AT zhimingeng whobenefitsfromr0resectionasinglecenteranalysisofpatientswithstageivgallbladdercancer
_version_ 1718385294989852672